We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
-1.26%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.29B
AUM Growth
+$61.5M
Cap. Flow
+$11.7M
Cap. Flow %
0.91%
Top 10 Hldgs %
37.9%
Holding
333
New
17
Increased
60
Reduced
147
Closed
33

Sector Composition

Rank Sector Weight
1 Technology 20.24%
2 Financials 8.46%
3 Healthcare 7.38%
4 Consumer Discretionary 6.37%
5 Industrials 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSS icon
76
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
$2.08M 0.16%
18,134
+560
+3% +$67.3K
NTR icon
77
Nutrien
NTR
$33.4B
$1.99M 0.15%
44,424
-27,051
-38% -$1.28M
NYT icon
78
New York Times
NYT
$12.1B
$1.93M 0.15%
37,165
J icon
79
Jacobs Solutions
J
$15.7B
$1.93M 0.15%
14,559
-3,767
-21% -$518K
REGN icon
80
Regeneron Pharmaceuticals
REGN
$75.9B
$1.91M 0.15%
2,686
+2,393
+817% +$2.01M
AVDV icon
81
Avantis International Small Cap Value ETF
AVDV
$18.9B
$1.84M 0.14%
28,204
+3,760
+15% +$253K
REGN icon
82
PUT
Regeneron Pharmaceuticals
REGN
$75.9B
0
MRK icon
83
Merck
MRK
$322B
$1.75M 0.14%
17,576
-7,235
-29% -$746K
USMV icon
84
iShares MSCI USA Min Vol Factor ETF
USMV
$23.4B
$1.72M 0.13%
19,380
-1,930
-9% -$177K
ADP icon
85
Automatic Data Processing
ADP
$105B
$1.71M 0.13%
5,845
-215
-4% -$63.5K
EQIX icon
86
Equinix
EQIX
$102B
$1.7M 0.13%
1,807
-41
-2% -$37.7K
MDT icon
87
Medtronic
MDT
$108B
$1.69M 0.13%
21,217
-557
-3% -$48.2K
GEM icon
88
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.67B
$1.69M 0.13%
52,912
-60,103
-53% -$2.04M
UMH
89
UMH Properties
UMH
$1.29B
$1.64M 0.13%
86,850
-3,400
-4% -$64.8K
PFF icon
90
iShares Preferred and Income Securities ETF
PFF
$13.2B
$1.6M 0.12%
50,785
-350
-0.7% -$11.4K
SYF icon
91
Synchrony
SYF
$24.7B
$1.57M 0.12%
24,200
-3,300
-12% -$202K
AL
92
DELISTED
Air Lease Corp
AL
$1.56M 0.12%
32,350
-1,850
-5% -$87.3K
EUSA icon
93
iShares MSCI USA Equal Weighted ETF
EUSA
$1.81B
$1.54M 0.12%
16,170
-3,267
-17% -$320K
YUM icon
94
Yum! Brands
YUM
$42.5B
$1.54M 0.12%
11,468
IQLT icon
95
iShares MSCI Intl Quality Factor ETF
IQLT
$13.8B
$1.53M 0.12%
41,321
+4,342
+12% +$170K
IEMG icon
96
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$1.49M 0.12%
28,620
-7,604
-21% -$421K
NEAR icon
97
iShares Short Maturity Bond ETF
NEAR
$4.83B
$1.4M 0.11%
27,739
-98,333
-78% -$4.99M
COP icon
98
ConocoPhillips
COP
$145B
$1.35M 0.1%
13,616
+95
+0.7% +$10.1K
BLDR icon
99
Builders FirstSource
BLDR
$7.07B
$1.33M 0.1%
9,300
-245
-3% -$43.4K
EFAV icon
100
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.32B
$1.33M 0.1%
18,776
+4,271
+29% +$314K

Similar funds

Shufro Rose & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Shufro Rose & Co held 333 positions worth $1.29B, up 5% from $1.23B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Shufro Rose & Co's Q4 2024 filing shows 17 new, 60 increased, 147 reduced and 33 closed positions. Its largest new stake was ALPS Smith Core Plus Bond ETF: 1,844,088 shares worth $47.1M. The largest sale was iShares iBonds Dec 2027 Term Corporate ETF, an estimated $48.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Shufro Rose & Co's largest Q4 2024 buy was ALPS Smith Core Plus Bond ETF: 1,844,088 shares worth $47.1M.
  • Shufro Rose & Co added most to VanEck Gold Miners ETF in Q4 2024, an estimated $20M increase.
  • Shufro Rose & Co's biggest Q4 2024 reduction was iShares iBonds Dec 2027 Term Corporate ETF, cutting an estimated $48.6M.
  • Shufro Rose & Co fully exited Moderna in Q4 2024, selling an estimated $17.4M.
  • Shufro Rose & Co's ten largest holdings make up 38% of its $1.29B portfolio in Q4 2024.
  • Shufro Rose & Co opened 17 new positions and closed 33 in Q4 2024.
  • Shufro Rose & Co's portfolio value rose 5% quarter-over-quarter to $1.29B.

Based on Shufro Rose & Co's 13F filing for Q4 2024, filed 25 Feb 2025.